| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/23/2011 | EP2297199A1 Interleukin-21 receptor binding proteins |
| 03/23/2011 | EP2297196A1 Vaccine against amyloid folding intermediate |
| 03/23/2011 | EP2296703A2 Igf-ii/gf-iie binding proteins |
| 03/23/2011 | EP2296689A1 Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
| 03/23/2011 | EP2084190B1 Lingo binding molecules and pharmaceutical use thereof |
| 03/23/2011 | EP1666591B1 Cytokine that induces apoptosis |
| 03/23/2011 | EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 03/23/2011 | EP1478753B1 Flavenoid methyltransferase from torenia and uses therefor |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1463529B9 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/23/2011 | EP1456364B1 Mutations in the b-raf gene |
| 03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/23/2011 | CN1922316B Mutants of anti-cd40 antibody |
| 03/23/2011 | CN101990575A Anti-(influenza a virus subtype h5 hemagglutinin) monoclonal antibody |
| 03/23/2011 | CN101990548A Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 03/23/2011 | CN101988925A ELISA (Enzyme Linked Immunosorbent Assay) reagent kit for detecting Hum j3 specific IgE antibodies |
| 03/23/2011 | CN101988070A White spot syndrome virus VP292 polypeptide and application thereof |
| 03/23/2011 | CN101988067A Prion isomer monoclonal antibody gene and application thereof |
| 03/23/2011 | CN101988050A H1N1 swine influenza virus-resistant hemagglutinin protein monoclonal antibody, hybridoma cell line and antigen-capture ELISA kit |
| 03/23/2011 | CN101987872A Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application |
| 03/23/2011 | CN101987871A Optimized fc variants and methods for their generation |
| 03/23/2011 | CN101987870A Optimized fc variants |
| 03/23/2011 | CN101987869A Anthracene artificial immunogen AN-L-Protein |
| 03/23/2011 | CN101987836A Chlorpromazine hapten, artificial antigen, antibody as well as preparation method and application thereof |
| 03/23/2011 | CN101649321B Arisaema amurense maxim agglutinin protein coding sequence and application thereof |
| 03/23/2011 | CN101357941B Preparation method of heat resistant bovine colostrum immunoglobulin |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910708 Interleukin-13 specific immunoglobulin for treatment of asthma, skin, vision, inflammatory, cell proliferative, fibrotic and allergic disorders |
| 03/22/2011 | US7910707 Anti-interferon-α antibodies |
| 03/22/2011 | US7910706 Humanized neutralizing antibodies against hemolytic uremic syndrome |
| 03/22/2011 | US7910705 Stable cell lines expressing HERG1a and HERG1b |
| 03/22/2011 | US7910704 Human p53 splice variant displaying differential transcriptional activity |
| 03/22/2011 | US7910693 Prostate cancer diagnosis and treatment |
| 03/22/2011 | US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/22/2011 | US7910540 Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | US7910337 Method for identifying drug-sensitizing antisense DNA fragments and use thereof |
| 03/22/2011 | US7910333 Antibodies to alpha-synuclein |
| 03/22/2011 | US7910332 Method for manufacturing a recombinant polyclonal protein |
| 03/22/2011 | US7910325 Screening agents which modulate formation of Fanconi anemia complementation group D2 (FANC D2) -containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein; determining a subject's sensitivity to a genotoxic agent |
| 03/22/2011 | US7910314 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 03/22/2011 | US7910117 Vaccine |
| 03/22/2011 | US7910106 Combinations of SAP depleting agents and anti-SAP antibodies |
| 03/22/2011 | US7910104 Modified anti-CD52 antibody |
| 03/22/2011 | US7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 03/22/2011 | US7910101 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 03/22/2011 | US7910100 Antibodies directed to the mammalian EAG1 ion channel protein |
| 03/22/2011 | US7910099 Antibodies to VLA-1 |
| 03/22/2011 | US7910098 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation |
| 03/22/2011 | US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 03/22/2011 | US7910095 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 03/22/2011 | US7910094 Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| 03/22/2011 | CA2510950C Cinnamic acid 4-hydroxylase |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2390166C Hedgehog fusion proteins and uses |
| 03/22/2011 | CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 03/22/2011 | CA2272844C Novel nucleic acid molecules from maize and their use for the production of modified starch |
| 03/22/2011 | CA2240409C Mammalian cx3c chemokine genes |
| 03/22/2011 | CA2223013C Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 03/22/2011 | CA2173750C Single-chain forms of the glycoprotein hormone quartet |
| 03/17/2011 | WO2011031833A2 Human anti-cancer antibodies |
| 03/17/2011 | WO2011031720A1 Bispecific nanobodies as a therapeutic for alzheimer's disease |
| 03/17/2011 | WO2011031695A1 High affinity human antibodies to human protease-activated receptor-2 |
| 03/17/2011 | WO2011031397A1 Method to improve virus removal in protein purification |
| 03/17/2011 | WO2011030935A1 Antibodies against glucagon receptor and their use |
| 03/17/2011 | WO2011030841A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4) |
| 03/17/2011 | WO2011030302A1 An isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof |
| 03/17/2011 | WO2011030107A1 Multivalent antibodies |
| 03/17/2011 | WO2011029996A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 03/17/2011 | WO2011029823A1 Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells |
| 03/17/2011 | WO2011029193A1 Method of treating cancer by inhibiting trim59 expression or activity |
| 03/17/2011 | WO2010138736A3 A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| 03/17/2011 | WO2010129713A3 Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject |
| 03/17/2011 | WO2010120069A3 Antigenic protein of black-lip pearl oyster egg extract, and method for assessing productive effort of black-lip pearl oyster using antibody specific to the protein |
| 03/17/2011 | WO2010035012A9 Biological products |
| 03/17/2011 | US20110065902 High affinity human antibodies to pcsk9 |
| 03/17/2011 | US20110065901 Methods For Purifying A Target Protein From One or More Impurities In A Sample |
| 03/17/2011 | US20110065900 Separation method utilizing polyallylamine ligands |
| 03/17/2011 | US20110065899 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 03/17/2011 | US20110065898 Immunosuppressant Target Proteins |
| 03/17/2011 | US20110065896 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 03/17/2011 | US20110065779 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same |
| 03/17/2011 | US20110065767 Substituted CC-1065 Analogs and Their Conjugates |
| 03/17/2011 | US20110065654 Compositions and methods for alzheimer's disease |
| 03/17/2011 | US20110065205 Method for determining prognosis of acute central nervous system disorder |
| 03/17/2011 | US20110065199 Atherosclerosis marker and use thereof |
| 03/17/2011 | US20110065198 Novel targets and compounds for therapeutic intervention of hiv infection |
| 03/17/2011 | US20110065197 Diagnostic kit for alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof |
| 03/17/2011 | US20110065185 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 03/17/2011 | US20110065178 Dendritic cell potentiation |
| 03/17/2011 | US20110065176 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof |
| 03/17/2011 | US20110065173 Vector |
| 03/17/2011 | US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases |
| 03/17/2011 | US20110065124 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 03/17/2011 | US20110065113 Recurrent gene fusions in prostate cancer |
| 03/17/2011 | US20110065095 Anti-(influenza a virus subtype h5 hemagglutinin) monoclonal antibody |
| 03/17/2011 | US20110065091 Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics |
| 03/17/2011 | US20110065090 Asymmetrically branched polymer conjugates and microarray assays |
| 03/17/2011 | US20110065089 Novel strain of sars-associated coronavirus and applications thereof |
| 03/17/2011 | US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith |